2021 Industry and Agency Support

2021 Foundation, Industry And Agency Support

We are proud to acknowledge the following for their contributions to and generous support of our program.

Premier

 



Angel




Patron

Agendia, Inc
Epic Sciences
Genentech
MacroGenics/Eversana
Natera
Tempus 

Major Supporter 

American Association for Cancer Research (AACR)
Eisai, Inc
Myriad Genetics
NeoGenomics Laboratories
The Oncologist
Veru, Inc

Contributors

10x Genomics
Agilent/Dako
Alamo Breast Cancer Foundation
Caris Life Sciences
Coherus Biosciences
Encore Medical Education, LLC
Foundation Medicine, Inc
Roche Information Solutions
R-pharm US
Spectrum Pharmaceuticals, Inc.


Donor 

CSI Laboratories
Dignitana
Elucent Medical
Endomag
Guardant Health
MD Anderson Cancer Center
Menarini Silicon Biosystems
OBI Pharma USA, Inc.
Olema Oncology
Oncocyte
Paxman USA, Inc.
Predicine, Inc
PreludeDX
Silbiotech
Stratpharma Switzerland
Tactile Medical
Tersera Therapeutics LLC
Veracyte
Viatris
Volpara Health
Xeos
Zero Gravity

Friend

Global Breast Cancer Conference
Greenwich LifeSciences, Inc
Harborside Press
Male Breast Cancer Coalition
METAvivor Research and Support, Inc
National Accreditation Program for Breast Centers
Pierre Fabre
PreciCa
Protean Biodiagnostics
Seno Medical


  SABCS gratefully acknowledges Eisai for support of the Career Development Forum, and Lilly for support of the Patient Advocate Lounge.


This activity is supported by an education grants provided by AstraZeneca, Daiichi-Sankyo, Eisai, Lilly, Novartis and Sanofi Genzyme.  For further information concerning Lilly grant funding visit www.lillygrantoffice.com

 

 Funding for this conference was made possible (in part) by 5R13CA213939-05 from the National Cancer Institute. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the US Government.